[go: up one dir, main page]

NO986165L - Preparat inneholdende taxan-analog for parenteral administrering - Google Patents

Preparat inneholdende taxan-analog for parenteral administrering

Info

Publication number
NO986165L
NO986165L NO986165A NO986165A NO986165L NO 986165 L NO986165 L NO 986165L NO 986165 A NO986165 A NO 986165A NO 986165 A NO986165 A NO 986165A NO 986165 L NO986165 L NO 986165L
Authority
NO
Norway
Prior art keywords
taxane
parenteral administration
analogous preparation
analogous
preparation
Prior art date
Application number
NO986165A
Other languages
English (en)
Norwegian (no)
Other versions
NO986165D0 (no
Inventor
Borje S Andersson
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24699210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO986165(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Texas filed Critical Univ Texas
Publication of NO986165D0 publication Critical patent/NO986165D0/no
Publication of NO986165L publication Critical patent/NO986165L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO986165A 1996-06-28 1998-12-28 Preparat inneholdende taxan-analog for parenteral administrering NO986165L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/672,594 US5877205A (en) 1996-06-28 1996-06-28 Parenteral paclitaxel in a stable non-toxic formulation
PCT/US1997/011503 WO1998000128A1 (fr) 1996-06-28 1997-06-26 Paclitaxel parenteral dans une formulation stable non toxique

Publications (2)

Publication Number Publication Date
NO986165D0 NO986165D0 (no) 1998-12-28
NO986165L true NO986165L (no) 1999-02-25

Family

ID=24699210

Family Applications (1)

Application Number Title Priority Date Filing Date
NO986165A NO986165L (no) 1996-06-28 1998-12-28 Preparat inneholdende taxan-analog for parenteral administrering

Country Status (9)

Country Link
US (2) US5877205A (fr)
EP (1) EP0920311A4 (fr)
JP (1) JP2000515132A (fr)
CN (1) CN1165300C (fr)
AU (1) AU722617B2 (fr)
CA (1) CA2259297C (fr)
NO (1) NO986165L (fr)
NZ (1) NZ333737A (fr)
WO (1) WO1998000128A1 (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964946B1 (en) * 1995-10-26 2005-11-15 Baker Norton Pharmaceuticals, Inc. Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
US6245805B1 (en) * 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
US20030157187A1 (en) * 1996-12-02 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory diseases
US6727280B2 (en) * 1997-01-07 2004-04-27 Sonus Pharmaceuticals, Inc. Method for treating colorectal carcinoma using a taxane/tocopherol formulation
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US20030087954A1 (en) * 1997-01-07 2003-05-08 Sonus Pharmaceuticals, Inc. Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
US20030105156A1 (en) * 1997-01-07 2003-06-05 Nagesh Palepu Method for administration of a taxane/tocopherol formulation to enhance taxane therapeutic utility
US6045815A (en) * 1997-08-15 2000-04-04 Board Of Regents, The University Of Texas System Parenteral pimaricin as treatment of systemic infections
US6844004B2 (en) 1997-08-15 2005-01-18 Board Of Regents, The University Of Texas System Topical formulations of natamycin/pimaricin
HUP0101564A3 (en) * 1998-02-05 2002-06-28 Novartis Ag Compositions containing epothilone
IL131217A0 (en) * 1998-03-10 2001-01-28 Napro Biotherapeutics Inc Novel methods and compositions for delivery of taxanes
KR19990075621A (ko) * 1998-03-23 1999-10-15 임성주 경사 평판형 배양조
KR100446959B1 (ko) * 1998-04-02 2004-11-03 김종국 파클리탁셀주사제조성물
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6017948A (en) * 1998-10-30 2000-01-25 Supergen, Inc. Water-miscible pharmaceutical compositions
ATE289801T1 (de) * 1998-12-22 2005-03-15 Us Health Verabreichungssystem für wasserunlösliche arzneistoffe
US6040330A (en) 1999-01-08 2000-03-21 Bionumerik Pharmaceuticals, Inc. Pharmaceutical formulations of taxanes
US6121257A (en) * 1999-03-31 2000-09-19 Abbott Laboratories Sulfamate containing macrocyclic immunomodulators
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
SE9903831D0 (sv) 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
US20040009229A1 (en) * 2000-01-05 2004-01-15 Unger Evan Charles Stabilized nanoparticle formulations of camptotheca derivatives
US6638973B2 (en) 2000-02-02 2003-10-28 Fsu Research Foundation, Inc. Taxane formulations
ES2390066T3 (es) 2000-05-12 2012-11-06 Samyang Biopharmaceuticals Corporation Procedimiento para la preparación de micelas poliméricas mediante separación de fase de un copolímero en bloque
US7217770B2 (en) * 2000-05-17 2007-05-15 Samyang Corporation Stable polymeric micelle-type drug composition and method for the preparation thereof
AU2001279168A1 (en) * 2000-08-02 2002-02-13 Atossa Healthcare, Inc. Bimodal emulsions of taxanes and butyrate polyalcohol esters
US6919370B2 (en) * 2000-11-28 2005-07-19 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
WO2003022248A1 (fr) * 2001-09-13 2003-03-20 Korea Institute Of Science And Technology Composition huileuse a base de paclitaxel, formulation pour chimio-embolisation, et procede d'elaboration
US20040092428A1 (en) * 2001-11-27 2004-05-13 Hongming Chen Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
HUP0600533A2 (en) * 2001-11-30 2006-11-28 Bristol Myers Squibb Co Paclitaxel solvates
US20060078618A1 (en) * 2001-12-11 2006-04-13 Constantinides Panayiotis P Lipid particles and suspensions and uses thereof
US20040213837A1 (en) * 2002-08-05 2004-10-28 Sankaram Mantripragada Oil-core compositions for the sustained release of hydrophobic drugs
US20050129719A1 (en) * 2003-12-15 2005-06-16 Yu-Fang Hu Concentrated emulsion formulation for silatecan
US20050220835A1 (en) * 2004-03-30 2005-10-06 Jayaraman Ramesh B Agent eluting bioimplantable devices and polymer systems for their preparation
JP4820758B2 (ja) * 2004-09-22 2011-11-24 日本化薬株式会社 新規ブロック共重合体、ミセル調製物及びそれを有効成分とする抗癌剤
WO2007014445A1 (fr) * 2005-08-02 2007-02-08 Miv Therapeutics Inc. Micro-dispositifs comprenant des nanocapsules pour l'administration controlee de medicaments et procede de fabrication idoine
KR20080106254A (ko) * 2006-03-28 2008-12-04 니폰 가야꾸 가부시끼가이샤 탁산류의 고분자 결합체
RU2447095C2 (ru) 2006-05-18 2012-04-10 Ниппон Каяку Кабусики Кайся Высокомолекулярный конъюгат подофиллотоксинов
US20090239782A1 (en) * 2006-10-03 2009-09-24 Masaharu Nakamura High-molecular weight conjugate of resorcinol derivatives
US8334364B2 (en) 2006-11-06 2012-12-18 Nipon Kayaku Kabushiki Kaisha High-molecular weight derivative of nucleic acid antimetabolite
US8188222B2 (en) 2006-11-08 2012-05-29 Nippon Kayaku Kabushiki Kaisha High molecular weight derivative of nucleic acid antimetabolite
WO2009041570A1 (fr) 2007-09-28 2009-04-02 Nippon Kayaku Kabushiki Kaisha Conjugué polymère-stéroïde
AR063111A1 (es) 2007-10-03 2008-12-30 Eriochem Sa Una formulacion farmaceutica de taxano
CN101977631A (zh) * 2008-03-18 2011-02-16 日本化药株式会社 生理活性物质的高分子量偶联物
JP5366940B2 (ja) 2008-05-08 2013-12-11 日本化薬株式会社 葉酸若しくは葉酸誘導体の高分子結合体
WO2010131675A1 (fr) 2009-05-15 2010-11-18 日本化薬株式会社 Conjugue polymere de substance bioactive comprenant un groupe hydroxy
CN102038635A (zh) * 2009-10-23 2011-05-04 天津天士力集团有限公司 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法
CN102038634B (zh) * 2009-10-23 2014-12-10 天士力控股集团有限公司 一种含有助溶剂的紫杉烷类药物溶液及其制备方法
CN102038636B (zh) * 2009-10-23 2014-08-13 天士力控股集团有限公司 一种含有螯合剂的紫杉烷类药物溶液及其制备方法
TWI438009B (zh) * 2010-02-19 2014-05-21 Teikoku Pharma Usa Inc 紫杉烷前－乳劑調配物及其製造與使用之方法
MX341082B (es) 2010-05-03 2016-08-08 Teikoku Pharma Usa Inc Formulaciones de pro-emulsion de taxano no acuosas y metodos para hacer y usar las mismas.
TWI472340B (zh) * 2010-11-10 2015-02-11 Tasly Holding Group Co Ltd Taxanes containing solution and a preparation method of the co-solvent
US9018323B2 (en) 2010-11-17 2015-04-28 Nippon Kayaku Kabushiki Kaisha Polymer derivative of cytidine metabolic antagonist
RU2623426C2 (ru) * 2011-09-11 2017-06-26 Ниппон Каяку Кабусики Кайся Способ получения блок-сополимера
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN109464382B (zh) * 2019-01-08 2020-10-09 四川大学 一种可注射的高载药量的紫杉醇凝胶及其制备方法和应用
AU2022369145A1 (en) * 2021-10-21 2024-05-23 Kashiv Biosciences, Llc Stable ready to dilute composition of carfilzomib

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2698543B1 (fr) * 1992-12-02 1994-12-30 Rhone Poulenc Rorer Sa Nouvelles compositions à base de taxoides.
US5430057A (en) * 1993-09-30 1995-07-04 Board Of Regents, The University Of Texas System Parenteral busulfan for treatment of malignant disease
US5597829A (en) * 1994-05-09 1997-01-28 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of camptothecin and methods for uses thereof
TW372967B (en) * 1994-12-27 1999-11-01 Kanebo Ltd 1,4 benzoxazine derivative, pharmaceutical composition containing the same and use thereof

Also Published As

Publication number Publication date
CN1165300C (zh) 2004-09-08
CA2259297C (fr) 2003-12-16
US6107333A (en) 2000-08-22
WO1998000128A1 (fr) 1998-01-08
NZ333737A (en) 2000-02-28
EP0920311A4 (fr) 2001-10-04
CA2259297A1 (fr) 1998-01-08
AU3647897A (en) 1998-01-21
NO986165D0 (no) 1998-12-28
US5877205A (en) 1999-03-02
CN1228022A (zh) 1999-09-08
JP2000515132A (ja) 2000-11-14
AU722617B2 (en) 2000-08-10
EP0920311A1 (fr) 1999-06-09

Similar Documents

Publication Publication Date Title
NO986165L (no) Preparat inneholdende taxan-analog for parenteral administrering
MA26816A1 (fr) Derives d'amino-triazolopyridine
DE69728676D1 (de) Substituierte 6,6-heterobicyclische derivate
ATE367150T1 (de) Arzneimittel
EE03824B1 (et) Valuvaigistava toimega ühendid
DE69928945D1 (de) 4,4-biarylpiperidinederivate mit opioid-receptor-wirkung
DE69706292D1 (de) Chinazoline derivate
DE50014884D1 (de) Horizontalspritzgiessmaschine
ID26743A (id) Turunan 1,2,4,5-tetrahidro-benzo [d] azepin
DE69809755D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalin derivate
NO996372L (no) Fast farmasøytisk preparat inneholdende benzofuanderivater
IS4848A (is) Lyfjafræðilega gagnleg efnasambönd
NO971137L (no) Dimetyl-(3-aryl-but-3-enyl)-aminforbindelse som farmasöytiske forbindelser
NO20005399L (no) Farmasöytisk preparat
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
ATE277917T1 (de) Alkylaminobenzothiazole und -benzoxazole derivate
NO995039D0 (no) Gastrisk bibeholdt farmasöytisk preparat
ATE213632T1 (de) Fungizide zusammensetzung mit erhörter bioverfügbarkeit
FI960121L (fi) Kombinaatioinjektiovalmiste
FI951155A0 (fi) Farmaseuttinen valmiste
FI961364L (fi) Lääkeainekoostumus
ATE199256T1 (de) Cyclopeptidderivate
NO971879D0 (no) Preparat for transdermal administrasjon
ATE240941T1 (de) 1,25-dihydroxy-16,22,23-trisdehydro- cholecalciferol-derivate
NO993024L (no) Polysakkarid-peptid-derivater